Teledyne expands healthcare sensing footprint with $1.1 billion Varex acquisition

Eighteen dollars and ninety cents per share is the price Teledyne Technologies has set to absorb Varex Imaging, a move that consolidates key components of the medical and industrial X-ray supply chain. The $1.1 billion all-cash deal, announced Monday, aims to integrate Varex’s specialized imaging subsystems into Teledyne’s broader sensing and instrumentation business. Varex shares rose nearly 50% in pre-market trading following the disclosure.

The acquisition targets a specific intersection of high-precision manufacturing and clinical diagnostics. Varex, based in Salt Lake City, produces the detectors and tubes essential for medical imaging, security screening, and industrial quality control. The deal allows Teledyne to capture a larger share of the margin in the life sciences sector, providing a stabilized platform for Varex, which has recently navigated supply chain volatility and shifting inventory trends in the Chinese market.

Management expects the transaction to close in early 2027, following customary regulatory approvals. The long lead time reflects the complexity of integrating global manufacturing footprints and the specialized nature of radiographic technology. For Teledyne, the acquisition is a calculated expansion into high-barrier markets where regulatory certifications and specialized physics provide a durable competitive moat.